Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/1995
10/31/1995US5463107 Useful in prophylaxis and treatment of diseases caused by excessive secretion of endothelin
10/31/1995US5463105 Therapy for cardiovascular, nervous system disorders
10/31/1995US5463104 Succinoylamino hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
10/31/1995US5463092 Viricides
10/31/1995US5463087 Substituted derivatives of deoxymyoinositol, process for their preparation and their use in medicaments
10/31/1995US5463083 2,5-diaryl tetrahydrothiophenes, tetrahydrofurans and 1,3-diaryl-cyclopentanes which act as platelet activating factor receptor antagonists and/or inhibitors of the enzyme 5-lipoxygenase
10/31/1995US5463078 Anisomycin derivatives and anticancer agents, antifungal agents and antiprotozoan agents containing the same
10/31/1995US5463074 Imidazolyl or imidazoylalkyl substituted with a four or five membered nitrogen containing heterocyclic ring
10/31/1995US5463071 Tetrazole derivatives; useful for inhibiting undesirable cell aggregation
10/31/1995US5463070 Hypoglycemic hydroxyurea derivatives
10/31/1995US5463063 Preparation of thalidomide; inhibitor of tumor necrosis factor
10/31/1995US5463062 Inhibitors of glucose-6-phosphatase system
10/31/1995US5463060 One-pot process
10/31/1995US5463053 Optically active pyridobenzoxazine derivatives
10/31/1995US5463049 Process for preparing enantiomerically pure imidazo[4,5,1-JK][1,4]-benzodiazepin-2(1H)-thiones
10/31/1995US5463048 Rapamycin amidino carbamates
10/31/1995US5463046 1-β-methyl-2-thiolic carbapenem derivatives
10/31/1995US5463035 Precipitation, chromatography using strongly basic anion exchange resin in borate form, crystallization
10/31/1995US5463028 Compound comprising a methyl ecgonine group chemically attached to a phenylphosphonic group which is an analog to an intermediate of the hydrolysis transition-state of a cocaine benzoyl ester group
10/31/1995US5463011 Allophanic acid derivatives from reacting amines with isocyanate components; anticoagulants; inhibits binding of fibrinogen to glycoprotein IIa/IIIb
10/31/1995US5462976 Photocurable glycosaminoglycan derivatives, crosslinked glycosaminoglycans and method of production thereof
10/31/1995US5462970 Polyamines and anti-diarrheal and gastrointestinal anti-spasmodic pharmaceutical compositions and methods of treatment
10/31/1995US5462969 Method and compositions for treatment or prevention of pneumocystic carinii infections
10/31/1995US5462968 EP2 -receptor agonists as agents for lowering intraocular pressure
10/31/1995US5462967 Feed additive for livestock and feed for livestock
10/31/1995US5462966 Methods for the prevention and control of cellular damage resulting from coronary artery occlusion-reperfusion
10/31/1995US5462965 Use of heterocyclic amino-alcohol compounds for treatment of CNS diseases
10/31/1995US5462963 Chelator compositions comprising α-diamine compounds
10/31/1995US5462962 Tetrahydrobenz[c,d]indole serotonin agonists
10/31/1995US5462960 Very good affinity for cannabinoid receptor; having psycho-tropic activity
10/31/1995US5462959 4-aryl-imidazole derivatives
10/31/1995US5462957 Azole derivatives, pharmaceutical compositions containing the same, and method for treating mycosis and estrogen-dependent diseases
10/31/1995US5462956 Epibatidine and derivatives, compositions and methods of treating pain
10/31/1995US5462953 Benzoxazolyl derivatives useful as 5-lipoxygenase inhibitors
10/31/1995US5462952 Fenamate 1,3,4-thiadiazoles and 1,3,4-oxadiazoles as antiinflammatory agents
10/31/1995US5462951 Dissolved in a polyoxyethylene sorbitan fatty acid ester and adsorbed onto a porosity inorganic substance
10/31/1995US5462950 Administering raloxifene or salt
10/31/1995US5462949 Methods of inhibiting fertility in women
10/31/1995US5462948 Treatment of addiction to drugs and substances of abuse
10/31/1995US5462947 Nervous system disorders
10/31/1995US5462946 Metal-independent nitroxide or oxazolidine-1-oxyl forming compound in biologically acceptable carrier to protect biological material from oxidative stress
10/31/1995US5462945 N-substituted trifluoromethylphenyltetrahydropyridines, process for the preparation thereof, intermediates in said process and pharmaceutical compositions containing them
10/31/1995US5462942 2,3-dihydro-1,4-benzodioxin-5-yl-piperazine derivatives having 5-HT 1A-antagonistic activity
10/31/1995US5462941 1-(cyclohexylalkylamino)-4-(phenyl, thienyl, or furyl) phthalazines; anti-platelet agglutination agents for treatment or prevention of cerebro- or cardiovascular disorders
10/31/1995US5462940 4-oxocyclic ureas useful as antiarrhythmic and antifibrillatory agents
10/31/1995US5462939 Treating infectious diseases, septic shock, respiratory diseases, inflammatory conditions, autoimmune diseases, bone diseases
10/31/1995US5462937 Methods for inhibiting vascular smooth muscle cell proliferation and restinosis
10/31/1995US5462936 Administering for treatment of hypertension and ischemic diseases
10/31/1995US5462935 Antibiotic
10/31/1995US5462933 Modified bile acid conjugates, and their use as pharmaceuticals
10/31/1995US5462932 Aqueous, buffered alendronate solution containing a complexing agent to prevent precipitation; bone loss prevention
10/31/1995US5462929 Treatment of psoriasis by administration of 4-carbamoyl-1-β-D-ribofuranosylimidszolium-5-oleate
10/31/1995US5462924 Product containing growth factor and glutamine and use of growth factor for the treatment of intestinal mucosa
10/31/1995US5462913 Pesticides, insecticides, miticides, herbicides
10/31/1995US5462752 Inhibition of platelet binding
10/31/1995US5462750 Metal, ceramic or polymeric particles coated with sugars or oligonucleotides which adsorb active materials, for drug delivery or medical diagnosis
10/31/1995US5462747 Dissolving povidone in alcohol, adding to dry mixture of active ingredient, ethyl cellulose, wicking agent, erosion promoter, drying, milling, blending with erosion promoter, wicking agent, lubricant, glidant, compressing into tablet
10/31/1995US5462745 Subsaturated transdermal therapeutic system having improved release characteristics
10/31/1995US5462726 Suppressing vasoconstriction
10/31/1995US5462724 Sensitizing agents for use in boron neutron capture therapy
10/31/1995US5462692 Stable solid acetylperoxyborate compounds
10/31/1995CA2079325C Nutritional supplement containing vitamin e
10/31/1995CA2042398C Orally administered porphyrins to control intestinal iron absorption
10/31/1995CA2030421C Agent for treatment of cerebrovascular contraction
10/31/1995CA2012194C Solid pharmaceutical composition containing nifedipine
10/31/1995CA2010037C Dual-action tablet
10/30/1995CA2148053A1 Non-peptidyl tachykinin receptor antagonists
10/30/1995CA2122551A1 Clearing of atherosclerosis
10/29/1995CA2146885A1 Therapeutic composition for corneal impairment
10/29/1995CA2146183A1 Environmentally safe cementitious germicide
10/28/1995CA2147930A1 Use of substituted amines for the treatment of brain function disorders
10/28/1995CA2147798A1 Nucleosides and oligonucleotides having 2'-ether groups
10/26/1995WO1995028484A1 Hek5, hek7, hek8, hek11, new eph-like receptor protein tyrosine kinases
10/26/1995WO1995028483A1 Cell-cycle regulatory proteins, and uses related thereto
10/26/1995WO1995028480A1 Methods of use of uncoated gel particles
10/26/1995WO1995028477A1 Differential cell migration
10/26/1995WO1995028419A1 Cck or gastrin modulating 5-heterocyclic-1,5-benzodiazepines
10/26/1995WO1995028407A1 Lobaplatinum trihydrate
10/26/1995WO1995028406A1 Rapamycin hydroxyesters, process for their preparation and pharmaceutical compositions containing them
10/26/1995WO1995028404A1 7,11 disubstituted camptothecin derivatives, formulations containing such derivatives and their use
10/26/1995WO1995028403A1 Abeo-ergoline derivatives as 5ht1a ligands
10/26/1995WO1995028401A1 Tropane-2-aldoxine derivatives as neurotransmitter reuptake inhibitors
10/26/1995WO1995028399A1 A method of inducing cholecystokinin agonist activity using 1,4-benzodiazepine compounds
10/26/1995WO1995028398A1 Novel crystal forms of 1-[5-methanesulfonamidoindolyl-2-carbonyl]-4-[3-(1-methylethylamino)-2-pyridinyl]piperazine
10/26/1995WO1995028397A1 Alpha1c adrenergic receptor antagonists
10/26/1995WO1995028393A1 Benzamide derivative, compositions containing said derivative and use thereof
10/26/1995WO1995028392A1 Chelant compounds
10/26/1995WO1995028391A1 Cck or gastrin modulating 1,5 benzodiazepines derivatives
10/26/1995WO1995028388A1 Quinolone derivative for treatment of urinary incontinence
10/26/1995WO1995028386A1 Substituted pyridine leukotriene b4 antagonists
10/26/1995WO1995028376A1 Inhibitors of influenza virus neuraminidase and methods of making and using the same
10/26/1995WO1995028227A1 Aqueous solvent encapsulation method, apparatus and microcapsules
10/26/1995WO1995028177A1 Medicinal composition for treating tardive dyskinesia and utilization thereof
10/26/1995WO1995028174A1 The combination of growth hormone and insulin-like growth factor, for treating congestive heart failure
10/26/1995WO1995028168A1 Treatment of diseases with hyssop officinalis extract
10/26/1995WO1995028165A1 Coated products with potent anti-hiv and antimicrobial properties
10/26/1995WO1995028163A1 Enteral formulations for the treatment of inflammation and infection containing a saponin, possibly in combination with other compounds
10/26/1995WO1995028162A1 Ameliorant or remedy for paraneoplastic syndrome
10/26/1995WO1995028160A1 Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties
10/26/1995WO1995028159A1 Compositions useful for glaucoma treatment
1 ... 6972 6973 6974 6975 6976 6977 6978 6979 6980 6981 6982 6983 6984 6985 6986 6987 6988 6989 6990 6991 6992 ... 7860